De-escalation of Adjuvant Radiation for Low-Risk HPV Oropharyngeal Cancers
Part of paid clinical trials in Washington D.C., District of Columbia.
- Sponsor
- Georgetown University
- Study ID
- NCT06554158
- Status
- Recruiting
Conditions
- Oropharynx Cancer
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Radiation Therapy — RADIATIONDe-escalation of Adjuvant Radiotherapy
Study Details
The goal of this clinical trial is to learn whether for intermediate-risk patients who have undergone Transoral Robotic Surgery for HPV/p16(+) oropharyngeal cancer and have minimal smoking history, whether these patients can be treated with a lower-than standard dose, with omission of the primary site in the oropharynx. The main questions it aims to answer are: Does radiotherapy site and dose-de-escalation lead to similar outcomes compared to historical data on tumor control in patients who are treated with standard radiation doses and treatment fields? Participants will: Undergo treatment with a lower than standard radiation dose (50Gy in 25 fractions, with either Intensity Modulated Radiation Therapy (IMRT) or proton beam therapy) and to a smaller than standard radiation field (to the neck only, excluding the original site of tumor in the oropharynx)
Key Dates
- Start date
- Aug 1, 2019
- Status verified
- Mar 2026
- Primary completion
- Dec 31, 2026
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 30 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Radiation dose: 50Gy50Gy in 25 fractions to the neck at risk for tumor recurrence, excluding the primary site
Primary Outcome Measure
Progression Free Survival (PFS) [ Time Frame: 2 year ]
Central Contacts
- Peter Ahn, MD(202) 444-4036
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Medstar Georgetown University Hospital | Washington D.C. | District of Columbia | 20007 | Peter Ahn, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Washington D.C., DC
Related Studies
- Testing Less Intensive Radiation With Chemotherapy to Treat Low-risk Patients With HPV-positive Oropharyngeal CancerPHASE2 · Recruiting · University of Missouri-Columbia · Columbia, Missouri
- Radiotherapy Dose De-escalation in HPV-Associated Cancers of the OropharynxRecruiting · Duke University · Durham, North Carolina
- A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)PHASE2 · Recruiting · Memorial Sloan Kettering Cancer Center · Miami, Florida
- Special Care Patterns for Elderly HNSCC Patients Undergoing RadiotherapyRecruiting · University Hospital Freiburg · Baltimore, Maryland